Undersøgelser i kaniner har vist, at kardiotoksiciteten af Caelyx er reduceret i forhold til konventionelle doxorubicinhydrochlorid præparationer.
Studies in rabbits have shown that the cardiotoxicity of Caelyx is reduced compared with conventional doxorubicin hydrochloride preparations.